33rd Annual Cardiovascular Interventions

March 29, 2022 — Today the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) approved the use of a second COVID-19 booster shot for adults over age 50 and certain immunocompromised individuals, including heart transplant patients.

March 29, 2022 – Cardiac computed tomography (CCT) is an accurate, noninvasive diagnostic test for obstructive coronary artery disease (CAD) according to an analysis recently published in The New England Journal of Medicine (NEJM), and poses less risk than the current standard diagnostic test for intermediate-risk patients of invasive coro

March 29, 2022 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, has received US Food and Drug Administration (FDA) clearance for its Solus Gold Embolization Device, a next-generation product for peripheral vascular occlusion.

March 29, 2022 – Eko, a digital health company advancing heart and lung disease detection, has announced the launch of its newly-redesigned Eko App, which will transform patient interactions into an opportunity to screen for cardiovascular disease. Heart disease is the leading cause of death in the U.S., and there has not been an efficient and affordable solution to screen for heart disease at the physical exam until now.

March 29, 2022 – Impulse Dynamics, a company dedicated to innovative treatments for chronic heart failure, has successfully completed the requirements for certification of its quality management system (QMS) under the new Medical Device Regulation

March 28, 2022 — HeartPoint Global, a leading medical device company dedicated to providing high-quality, minimally invasive cardiac care globally, announced another major milestone in the ongoing pre-clinical trials of the HeartPoint Global Implant System (HPGS), a first-of-its-kind patented, adjustable system which focuses on treating devastating left heart diseases, congestive heart failure, and

March 28, 2022 — Carmat, the designer and developer of the world’s most advanced total artificial heart, aiming to fulfill an unmet medical need by providing a therapeutic alternative to people suffering from end-stage biventricular heart failure, issues an update on its activities and outlook.

March 25, 2022 – In the first study to examine differences by sex and race in outcomes following the seven most common procedures for heart problems, researchers found that women are less likely to undergo these procedures—and even when women do receive these procedures, they are more likely than men to die while in the hospital, according to data that will be presented at the American College of Cardiology’s 71st Annual Scientific Session.

March 25, 2022 – Consumers are increasingly using smartwatches and other wearable devices to measure their heart rate and rhythm during exercise and for overall health monitoring. However, those measurements may be less accurate in people with darker skin tones, according to a study presented at the American College of Cardiology’s 71st Annual Scientific Session.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now